Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay.
Johnson, Stuart MD; Kent, Sara A. MD; O'Leary, Kevin J. MD; Merrigan, Michelle M. MS; Sambol, Susan P. BS; Peterson, Lance R. MD; Gerding, Dale N. MD
[Miscellaneous Article] Annals of Internal Medicine. 135(6):434-438, September 18, 2001.

(Format: HTML, PDF)

Background: Many clinical laboratories use toxin A immunoassays to test for Clostridium difficile.

Objective: To describe the clinical course of a patient infected with a toxin variant strain of C. difficile that was not detected by toxin A immunoassay; to genetically characterize this strain; and to estimate the number of laboratories that use only toxin A immunoassays.

Design: Case report, molecular investigation, and laboratory survey.

Setting: Tertiary care hospital in Chicago, Illinois.

Patient: An 86-year-old man.

Measurements: Restriction endonuclease analysis, polymerase chain reaction, and survey of regional clinical laboratories.

Results: An elderly hospitalized man died of advanced pseudomembranous colitis. Four stool specimens submitted over a 2-month period had tested negative on toxin A immunoassay, but a strain of C. difficile with a 1.8-kb deletion of the toxin A gene was recovered from each specimen. This strain, identified as restriction endonuclease analysis type CF4, is closely related to a widely disseminated variant, toxinotype VIII. Toxin A immunoassay was the only test being performed for detection of C. difficile at 31 of 67 (46%) regional clinical laboratories.

Conclusions: Toxin A variant strains of C. difficile cause serious disease and are undetectable in clinical laboratories that use only toxin A immunoassays for C. difficile testing.

(C) 2001 American College of Physicians